1-8 of 8
Yara Banz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Generation Natural Killer Cell-Mimic Nanoparticles for Active Targeting of Acute Myeloid Leukemia

Hojjat Alizadeh Zeinabad, Wen Jie Yeoh, Philippe Krebs, Carsten Riether, Mihai Lomora, Yara Banz, Eva Szegezdi
Journal: Blood
Blood (2022) 140 (Supplement 1): 10682–10683.
https://doi.org/10.1182/blood-2022-166893
Published: 2022
Journal Articles

Ribonuclease Inhibitor 1 (RNH1) Regulates Myeloid Lineage Choice through Cyclin-Dependent Kinase 1

Nicola Daniele Andina, Mayuresh Anant Sarangdhar, Aubry Tardivel, Camille Ansermet, Giuseppe Bombaci, Mahmoud Hallal, Vijay Kumar Chennupati, Yara Banz, Manfred Heller, Anne Angelillo-Scherrer, Nicolas Bonadies, Ramanjaneyulu Allam
Journal: Blood
Blood (2022) 140 (Supplement 1): 5726–5727.
https://doi.org/10.1182/blood-2022-168720
Published: 2022
Journal Articles

Correlation between the Degree of Bone Marrow Involvement and the Results of NGS in Plasma Cell Neoplasms

Ekaterina Rebmann Chigrinova, MD PhD, Naomi A. Porret, PhD, Gertrud Wiedemann, PhD, Martin Andres, MD, Yara Banz, MD PhD, Myriam Legros, Matthias Pollak, MD, Elisabeth Oppliger Leibundgut, Thomas Pabst, MD, Ulrike Bacher
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-142009
Published: 2020
Journal Articles

Targeting CD70 with Cusatuzumab Eliminates Acute Myeloid Leukemia Stem Cells in Humans

Adrian F Ochsenbein, MD, Thomas Pabst, MD, Sabine Höpner, PhD, Vera Ulrike Bacher, Magdalena Hinterbrandner, Msc, Yara Banz, Rouven Müller, MD, Markus G. Manz, Prof.Dr.MD, Walid Gharib, David Francisco, Rémy Bruggmann, PhD, Luc Van Rompaey, PhD, Mahan Moshir, MSc, Tim Delahaye, MSc, Domenica Gandini, Ellen Erzeel, Anna Hultberg, PhD, Samson Fung, MD, Hans De Haard, Nicolas Leupin, Carsten Riether, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 234.
https://doi.org/10.1182/blood-2019-129916
Published: 2019
Journal Articles

Rebound Thrombocytosis after Induction Chemotherapy Is a Strong Biomarker for Favorable Outcome in AML Patients

Thomas Pabst, MD, Bianca R Schnell, Ulrike Bacher, Barbara Jeker, Yara Banz, Urban Novak, Katja - Seipel
Journal: Blood
Blood (2019) 134 (Supplement_1): 5101.
https://doi.org/10.1182/blood-2019-127984
Published: 2019
Journal Articles

Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial

Adrian F Ochsenbein, MD, Carsten Riether, PhD, Ulrike Bacher, Rouven Müller, MD, Sabine Höpner, PhD, Yara Banz, Magdalena Hinterbrandner, Msc, Mario Bargetzi, MD, Markus G. Manz, MD, Luc Van Rompaey, PhD, Mahan Moshir, MSc, Tim Delahaye, MSc, Domenica Gandini, MD PhD, Ellen Erzeel, Anna Hultberg, PhD, Samson Fung, MD, Hans De Haard, PhD, Nicolas Leupin, MD, Thomas Pabst, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2680.
https://doi.org/10.1182/blood-2018-99-118302
Published: 2018
Journal Articles

CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas

Mélanie Juilland, Montserrat Gonzalez, Tabea Erdmann, Yara Banz, Zala Jevnikar, Stephan Hailfinger, Alexandar Tzankov, Michael Grau, Georg Lenz, Urban Novak, Margot Thome
Journal: Blood
Blood (2016) 127 (14): 1780–1789.
https://doi.org/10.1182/blood-2015-07-655647
Published: 2016
Includes: Supplemental data
Journal Articles

The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase–dependent cleavage of calreticulin in AML patients

Sarah Mans, Yara Banz, Beatrice U. Mueller, Thomas Pabst
Journal: Blood
Blood (2012) 120 (13): 2690–2699.
https://doi.org/10.1182/blood-2012-02-412759
Published: 2012
Includes: Supplemental data